Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chemoinformatics approaches to virtual screening and in silico design Alexandre Varnek Laboratoire d’Infochimie, Université de Strasbourg

Similar presentations


Presentation on theme: "Chemoinformatics approaches to virtual screening and in silico design Alexandre Varnek Laboratoire d’Infochimie, Université de Strasbourg"— Presentation transcript:

1 Chemoinformatics approaches to virtual screening and in silico design Alexandre Varnek Laboratoire d’Infochimie, Université de Strasbourg http://infochim.u-strasbg.fr/

2 Strasbourg Paris

3 Laboratory of Chemoinformatics Master on Chemoinformatics (since 2002)

4 Chemoinformatics: new disciline combining several „old“ fields Chemical databases, QSAR, Virtual screening, In silico design, ……………..

5 Needs for chemoinformatics Fundamentals of chemoinformatics Some applications OUTLOOK

6 Chemoinformatics: why

7 amount of information many millions of compounds and reactions many millions of publications Chemical Databases Storage, organization and search experimental data

8 May 2009September 2010 54,984,228 62,105,511 39,804,330 281,474 43,995,234 831,886 +7 M +2 M +22 M

9 Problem: Flood of Information > 54 million compounds > 5 million new compounds / year 800,000 publications / year => can anyone read 4.000 publications / day ? chemical information should be well organized and searchable

10 Problem: Not Enough Information > 54,000,000 chemical compounds > 500,000 3D structures in Cambridge Crystallographic File 230,000 infrared spectra in largest database (Bio-Rad) > 1 % of all compounds 0.4 % of all compounds The goal of chemoinfomatics is to develop predictive approaches and tools What about physico-chemical and biological properties ?

11 Chemoinformatics as a modeling discipline

12 What structure do I need for a certain property ? How do I make this structure ? What is the product of my reaction ? Chemoinfomatics as a modeling discipline structure-activity relationships synthesis design reaction prediction, structure elucidation

13 Theoretical chemistry Quantum Chemistry Force Field Molecular Modelling Chemoinformatics - Molecular model - Basic concepts - Major applications - Learning approaches

14 Molecular Model Quantum Chemistry Force Field Molecular Modelling Chemoinformatics molecular graph descriptor vector electrons and nuclei atoms and bonds

15 Basic mathematical approaches Quantum Chemistry Force Field Molecular Modelling Chemoinformatics Schrödinger equation, HF, DFT, … Classical mechanics Statistical mechanics -Graph theory, -Statistical Learning Theory

16 Basic concepts Quantum Chemistry Force Field Molecular Modelling Chemoinformatics chemical space wave/particle dualism classical mechanics

17 Chemical space = objects + metrics Objects: - molecular graphs; - descriptors vectors {D i } = f ( ) Metrics: - Graphs hierarchy, - Similarity measures

18 Navigation in Chemical Space: topological space of chemical structures Relationships between the objects: Hierarchical scaffold-tree approach Structural mutation rules Network-like Similarity Graphs Combinatorial Analog Graphs …………. Rational organisation of structural data Exploration of the chemical space Identification of new objects (e.g., active scaffolds, R-groups combinations, etc)

19 Navigation in Chemical Space: vectorial space defined by molecular descriptors Relationships between the objects: In this space, each molecule is represented as a vector whereas the metric is defined by similarity measures. In properly selected spaces, neighboring molecules possess similar properties. Different databases could be compared. Compounds subsets for screening could be rationally selected

20 Physicochemical parameters can be broadly classiied into three general types: Electronic (  ) Steric (  E s ) Hydrophobic (logP) Example :Hansch Analysis Biological Activity = f (Physicochemical parameters ) + constant log1/C = a ( log P ) 2 + b log P +  +  E s + C

21 Constitutional(mol. weight, the number of S, N or O atoms, …) Topological(Randic index, informational content, …) Geometrical(molecular size, distances between functional groups, … ) Electrostatic(electrostatic potential, charges, …) Charged Partial Surface Area Quantum-chemical(energies of molecular orbitals, reactivity indices, …) Thermodynamical(heat of formation, logP, …) Fragments(sequences of atoms and bonds, augmented atoms, …) More than 4000 types of descriptors are known Molecular Descriptors

22 Learning approach Quantum Chemistry Force Field Molecular Modelling Chemoinformatics deductive >> inductive deductive  inductive deductive << inductive

23 In chemoinformatics the logic of learning is not based on existing physical theories. Chemoinformatics considers the world too complex to be a priori described by any set of rules. Thus, the rules (models) in chemoinformatics are not explicitly taken from rigorous physical models, but learned inductively from the data. Learning approach

24 Chemoinformatics: From Data to Knowledge know- ledge information data generalization context measurement or calculation deductive learning inductive learning

25 In chemoinformatics, a model represents an ensemble of rules or mathematical equation linking a given property (activity) with the molecular structure. Models PROPERTY= f (structure) Two main types of models: - binary classification (SAR) - regression (QSAR)

26 Organic chemistry: exercise of « intuitive » chemoinformatics

27 The Markovnikov Rule: When a Brønsted acid, HX, adds to an unsymmetrically substituted double bond, the acidic hydrogen of the acid bonds to that carbon of the double bond that has the greater number of hydrogen atoms already attached to it. Extraction of rules from the data

28 In silico design Chemical Databases Virtuel screening Major applications Structure-Activity Models Machine-learning approaches: - MLR, -Decision Trees, - Artificial Neural Networks, - Support Vector Machines, -……… Algorithms for organisation and search the data - fingerprints, - graph theory, - similarity measures,

29 Chemoinformatics: some applications

30 Dmitry Mendeleév (1834 – 1907) Russian chemist who arranged the 63 known elements into a periodic table based on atomic mass, which he published in Principles of Chemistry in 1869. Mendeléev left space for new elements, and predicted three yet-to-be-discovered elements: Ga (1875), Sc (1879) and Ge (1886). Discoverer of the Periodic Table — an early “Chemoinformatician ”

31 Periodic Table Chemical properties of elements gradually vary along the two axis

32 Target Protein Large libraries of molecules High Throughout Screening Hit experiment computations Virtual Screening Small Library of selected hits

33 Chemical universe: > 50 M compounds are currently available 10 60 druglike molecules could be synthesised Virtual screening is inevitable to analyse a huge amount of protein-ligand combinations Virtual screening must be very fast and efficient ! Human proteome: 84000 peptides

34 ~10 6 – 10 9 molecules VIRTUAL SCREENING INACTIVES HITS CHEMICAL DATABASE Virtual screening “funnel” Similarity search Filters (Q)SAR Docking Pharmacophore models ~10 1 – 10 3 molecules

35 REACh regulation The European Union adopted Regulation on the Registration, Evaluation, Authorisation, and Restriction of Chemicals (the “REACH Regulation”), which entered into force on June 1, 2007. REACH imposes requirements of information of physico-chemical, toxicology and eco-toxicology parameters for the chemicals, production of which exceeds 1 ton. More than 30.000 compounds must be tested. Total cost estimated (EU Commission) over a 11 -15 year period is €2.8 - €5.2 bn No Data, No Market!

36 predictions of > 20 physico-chemical properties and NMR spectra for each individual compound Chemoinformatics tools in SciFinder:

37 Drug design

38 Virtual screening - what does it give us? Herbert Koppen (Boehringer, Germany) Current Opinion Drug Discovery & Dev. (2009) 12: 397-407 From virtuality to reality Ulrich Rester (Bayer, Germany) Current Opinion Drug Discovery & Dev. (2008) 11: 559-568 What has virtual screening ever done for drug discovery? David E Clark (Argenta Discovery Ltd, UK) Expert Opinion on Drug Discovery (2008) 8: 841-851 Virtual screening: success stories & drugs

39 39 Market: tirofiban (1999) Aggrastat (trade name) from Merck, GP IIb/IIIa antagonist (myocardial infarction, it is an anticoagulant)) (2S)-2-(butylsulfonylamino)-3-[4-[4-(4-piperidyl)butoxy]phenyl propanoic acid (Mol. Mass: 440.6 g/mol) PK data: Bioavailability: IV only (intravenous only); Half life : 2 hours Combined with heparin and aspirin, but numerous precautions http://www.bioscience.ws/encyclopedia/ In silico screening: success stories & drugs

40 Materials design

41 Ionic Liquids Ionic Liquids are composed of large organic cations: PF 6 -, Cl -, BF 4 -, CF 3 SO 3 -, [CF 3 SO 2 ) 2 N] - and anions:

42 There exist combinations of ions that could lead to useful ionic liquids Ionic Liquids Large organic cations: PF 6 -, Cl -, BF 4 -, CF 3 SO 3 -, [CF 3 SO 2 ) 2 N] - anions: 10 18

43 Viscosity predictions on 23 new ILs Solvionics company None of these Ionic Liquids have been used for model preparation

44 Ionic Liquids viscosity: Experimental validation of the Neural Networks models prediction error (~70 cP) is similar to the “noise” in the experimental data used for the training of the model exp pred G. Marcou, I. Billard, A. Ouadi and A. Varnek, submitted RMSE=73 cP

45 Metabolites prediction

46 Prediction of aromatic hydroxylation sites for human CYP1A2 substrates aromatic hydroxylation Potential hydroxylation sites CYP1A2 ? ? ? ? The obtained model correctly predicts the hydroxylation products with the probability of ≈80% (see poster of C. Muller) Method: SVM + descriptors issued from condensed graphs of reaction

47 Reaction conditions

48 Search of optimal reaction conditions reaction query Potential products of the reaction. The compound A is a target ABC + H 2

49

50 Experimental validation Sub A Conditions suggested by the program Expérimental validation catalystsolventadditifYield (Exp) 1Pt/C (10%)THFNone A : 98 % 2Pt/C (10%)DMFNone A : 90 %, Sub : 2% 3Ir/CaCO3 (5%)EtOHNEt3 (5 %) A : 100 % 4Ir/CaCO3 (5%)HexaneNone INSOLUBLE 5Ir/CaCO3 (5%)DMFNone A : 27%, Sub : 69 % + H 2 A. Varnek, in “Chemoinformatics and Computational Chemical Biology", J. Bajorath, Ed., Springer, 2010

51 Joseph Louis Gay-Lussac, Mémoires de la Société d ’Arcueil 2:207 (1808) « We are perhaps not far removed from the time when we shall be able to submit the bulk of chemical phenomena to calculation »

52

53 Visit our website : http://infochim.u-strasbg.fr


Download ppt "Chemoinformatics approaches to virtual screening and in silico design Alexandre Varnek Laboratoire d’Infochimie, Université de Strasbourg"

Similar presentations


Ads by Google